Esmolol: A titratable short-acting intravenous beta blocker for acute critical care settings
- 31 October 1987
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 114 (4), 866-885
- https://doi.org/10.1016/0002-8703(87)90797-6
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Hemodynamic Effects of Esmolol, an Ultrashort-acting Beta BlockerThe Journal of Clinical Pharmacology, 1987
- Esmolol-Digoxin Drug InteractionThe Journal of Clinical Pharmacology, 1987
- Cardiovascular and Neuromuscular Effects of Esmolol During Induction of AnesthesiaThe Journal of Clinical Pharmacology, 1986
- Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.Circulation, 1985
- THE EFFECT OF ESMOLOL ON THE ONSET AND DURATION OF SUCCINYLCHOLINE- INDUCED NEUROMUSCULAR BLOCKADEAnesthesiology, 1985
- EFFECT OF ESMOLOL ON HEART RATE AND BLOOD PRESSURE DURING INTUBATION IN RELATIVELY HEALTHY PATIENTSAnesthesiology, 1985
- Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery.Circulation, 1984
- Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patientLife Sciences, 1982
- Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man.Circulation, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981